Type 2 immunity drives progression of NAFLD

被引:0
|
作者
Katrina Ray
机构
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:505 / 505
相关论文
共 50 条
  • [21] Airway epithelial TSLP production of TLR2 drives type 2 immunity in allergic airway inflammation
    Lv, Jiajia
    Yu, Qianying
    Lv, Jie
    Di, Caixia
    Lin, Xiaoliang
    Su, Wen
    Wu, Min
    Xia, Zhenwei
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 (11) : 1838 - 1850
  • [22] Group 2 innate lymphoid cell activation in the neonatal lung drives type 2 immunity and allergen sensitization
    Steer, Catherine A.
    Martinez-Gonzalez, Itziar
    Ghaedi, Maryam
    Allinger, Patricia
    Mathae, Laura
    Takei, Fumio
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 140 (02) : 593 - +
  • [23] The role of adiponectin in NAFLD progression
    Esmaili, S.
    George, J.
    Hebbard, L.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 9 - 9
  • [24] Infections as predictors of NAFLD progression
    Cangemi, Roberto
    Miglionico, Marzia
    Basili, Stefania
    INTERNAL AND EMERGENCY MEDICINE, 2022, 17 (08) : 2185 - 2186
  • [25] Infections as predictors of NAFLD progression
    Roberto Cangemi
    Marzia Miglionico
    Stefania Basili
    Internal and Emergency Medicine, 2022, 17 : 2185 - 2186
  • [26] TRIB3-TRIM8 complex drives NAFLD progression by regulating HNF4 a stability
    Xiao, Meng -Chao
    Jiang, Nan
    Chen, Li -Lin
    Liu, Fang
    Liu, Shu-Qing
    Ding, Chen-Hong
    Wu, Si-Han
    Wang, Ke-Qi
    Luo, Yuan-Yuan
    Peng, Yu
    Yan, Fang-Zhi
    Zhang, Xin
    Qian, Hui
    Xie, Wei -Fen
    JOURNAL OF HEPATOLOGY, 2024, 80 (05) : 778 - 791
  • [27] Aberrant type 1 immunity drives susceptibility to mucosal fungal infections
    Break, Timothy J.
    Oikonomou, Vasileios
    Dutzan, Nicolas
    Desai, Jigar, V
    Swidergall, Marc
    Freiwald, Tilo
    Chauss, Daniel
    Harrison, Oliver J.
    Alejo, Julie
    Williams, Drake W.
    Pittaluga, Stefania
    Lee, Chyi-Chia R.
    Bouladoux, Nicolas
    Swamydas, Muthulekha
    Hoffman, Kevin W.
    Greenwell-Wild, Teresa
    Bruno, Vincent M.
    Rosen, Lindsey B.
    Lwin, Wint
    Renteria, Andy
    Pontejo, Sergio M.
    Shannon, John P.
    Myles, Ian A.
    Olbrich, Peter
    Ferre, Elise M. N.
    Schmitt, Monica
    Martin, Daniel
    Barber, Daniel L.
    Solis, Norma, V
    Notarangelo, Luigi D.
    Serreze, David, V
    Matsumoto, Mitsuru
    Hickman, Heather D.
    Murphy, Philip M.
    Anderson, Mark S.
    Lim, Jean K.
    Holland, Steven M.
    Filler, Scott G.
    Afzali, Behdad
    Belkaid, Yasmine
    Moutsopoulos, Niki M.
    Lionakis, Michail S.
    SCIENCE, 2021, 371 (6526) : 252 - +
  • [28] HEPATOCYTE-SPECIFIC UBC13 DELETION DRIVES NAFLD PROGRESSION VIA CELLULAR SENESCENCE AND GLUTAMINOLYSIS
    Reolizo, Lien
    Seki, Ekihiro
    HEPATOLOGY, 2023, 78 : S1103 - S1104
  • [29] Global prevalence of type 2 diabetes and NAFLD
    Krome, Susanne
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2024, 62 (03): : 369 - 370
  • [30] Type-1 immunity drives early lethality in scurfy mice
    Suscovich, Todd J.
    Perdue, Nikole R.
    Campbell, Daniel J.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2012, 42 (09) : 2305 - 2310